JMSB vs VRTX · P/E 13, rev $113.3M vs P/E 30, rev $3.33B
John Marshall Bancorp Inc (JMSB) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
John Marshall Bancorp Inc (JMSB) is a banks - regional company listed on NASDAQ.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported JMSB revenue for 2025-12-31 was $113.3M. Net income was $21.2M. Revenue was up 2.8% from 2024-12-31 to 2025-12-31. JMSB currently screens at market cap $300.6M and trailing P/E 13.5.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
JMSB currently screens at market cap $300.6M and trailing P/E 13.5. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the JMSB and VRTX stock pages for the full models.
Not investment advice.